Pamela R Macirowski, APN | |
43 Main St Ste 1, Farmingdale, NJ 07727-1341 | |
(732) 938-6471 | |
Not Available |
Full Name | Pamela R Macirowski |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 43 Main St Ste 1, Farmingdale, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245009463 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WM0705X | Registered Nurse - Medical-surgical | 26NR21841000 (New Jersey) | Secondary |
363LF0000X | Nurse Practitioner - Family | 26NJ15005300 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Pamela R Macirowski, APN 43 Main St Ste 1, Farmingdale, NJ 07727-1341 Ph: (732) 938-6471 | Pamela R Macirowski, APN 43 Main St Ste 1, Farmingdale, NJ 07727-1341 Ph: (732) 938-6471 |
News Archive
Fluxion Biosciences, Inc. announced today that a lawsuit alleging patent infringement had been filed against it in the US District Court of Northern California by Cellectricon AB, its competitor in the field of automated ion channel screening systems for drug discovery. Cellectricon has asserted U.S. Patents Nos. 7,390,650, 7,470,518, and 7,563,614 in the litigation, as well as U.S. Patent No. 5,376,252, which is owned by Gyros and licensed to Cellectricon.
Five Dartmouth College alumni and health care investors have committed a total of $1.4 million in gifts to launch the Dartmouth Innovations Accelerator for Cancer.
It's hard to think of any major portion of President Obama's health policy that hasn't engendered intense argument. But one at least comes close: the provision of the 2009 federal stimulus law that pushes medical practices to update their record-keeping for the 21st century.
GENova Biotherapeutics Inc. ("GENova") today announced it has signed an LOI with Prime BioResearch, Ltd. ("Prime BioResearch"), another drug acquisition company in the areas of drug development and distribution a business case that will save GENova millions every year in drug development and at the same time more than double GENova's distribution network enabling GENova to potentially exceed its own expectations of reaching 100m+ in revenue in year.
Based on new evidence, the age of introduction of gluten into the infant diet - or the practice of introducing gluten during breast-feeding - does not reduce the risk of celiac disease in infants at risk, according to a Position Paper of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition.
› Verified 9 days ago
Mr. David Charles Smerina, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14 Alexis Dr, Farmingdale, NJ 07727 Phone: 732-938-4836 |